FORM DEF 14A

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

October 11, 2022

Period of Report

November 10, 2022

Accession Number

0001437749-22-023855

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →